References | Region | Sample size/unit of analysis | Percentage of antibiotics prescribed | The most commonly prescribed antibiotic classes (from most to least) | The most commonly prescribed antibiotics (from most to least) |
---|---|---|---|---|---|
Khaksari et al. (1995 and 2000) [63] | Rafsanjan | 6895 prescriptions | 55.5 | NM | NM |
Mousavi et al. [64] | Iran (all provinces) | NM (prescription data from all around the country) | 45 | NM | NM |
Makouei et al. [65] | Urmia | 1090 prescriptions | 53 | Penicillin, Sulfonamides, Cephalosporin, Aminoglycosides, Macrolides | Penicillin, Amoxicillin, Ampicillin, Co-amoxiclav, Cloxacillin |
Dinarvand et al. [66] | Tehran | NM (prescriptions in 55 pharmacy) | 43 | NM | NM |
Soleymani et al.(1998–2009) [67] | Iran (all provinces) | 200 million prescriptions | 53.1 | NM | NM |
Moghaddam Nia et al. [68] | Babol | 4000 prescriptions | 61.9 | NM | NM |
Arab et al. [69] | Khuzestan | 986 prescriptions | 17.1 | NM | NM |
Cheragh Ali et al. [29] | Iran (100 primary care settings from 5 provinces of Tehran, Fars, Khorasan, Khuzestan, Kermanshah) | NM (prescriptions in 100 primary care settings) | 58 | NM | Amoxicillin, Procaine Penicillin |
Karimi et al. [70] | Savojbolagh | 1068 prescriptions | 56.8 | NM | Penicillin, Azithromycin, Penicillin 6.3.3, Cefixime, Co-amoxiclav |
Sepehri et al. [71] | Kerman | 45,384 prescriptions | 33.95 | Penicillin, Cephalosporin, Aminoglycosides | NM |
Alikhani et al. [72] | Yasuj | 441 prescriptions | 64.6 | Penicillin, Macrolides, Cephalosporin, Nalidixic-acid, Sulfonamides, | Erythromycin, Amoxicillin, Co-amoxiclav, Penicillin, Cefixime, |
Sepehri et al. [73] | Bam | 3000 prescriptions | 11.2 | Penicillin, Cephalosporin, Macrolides, Tetracycline, Aminoglycosides | Amoxicillin, Penicillin G, Cephalexin, Penicillin 6.3.3, Co-trimoxazole, |
Bastani et al. (2003–2013) [74] | Iran (all provinces) | 59 million prescriptions in each year | 53.33 | NM | NM |
Sadeghi et al. [75] | Khorasan Jonubi | 1,423,642 prescriptions | 42 | NM | Amoxicillin, Cefixime |
Ghadimi et al. [76] | East Azarbayjan | 2041 prescriptions | 39.2 | NM | NM |
Sasan et al. [77] | Mashhad | 1000 infants and children | 32.7 | NM | Penicillin 6.3.3, Co-trimoxazole, Ampicillin, Gentamicin, Amoxicillin |
Masoud et al. (2005–2015) [78] | Kerman | 15,784,313 prescriptions | 41.42 | NM | NM |
Dolat Abadi et al. [79] | Sabzevar | 167,305 prescriptions | 45 | NM | Amoxicillin |
Ahmadi et al. [80] | Ahvaz | 9524 prescriptions | 17.7 | NM | NM |
Sepehri et al. [81] | Bam | 297,104 prescriptions | 45.5 | Penicillin, Cephalosporin | Ciprofloxacin, Metronidazole, Amoxicillin |
Zare Shahi et al. [82] | Kerman | 410,218 prescriptions | 40 | NM | NM |
Mosleh et al. [83] | Tehran | 3420 prescriptions | 56.49 | NM | NM |
Sadeghian et al. [84] | Isfahan | 7,999,530 prescriptions | 25.31 | Penicillin, Cephalosporin, Macrolides, Quinolones, Sulfonamides | NM |
Safaeian et al. [85] | Isfahan | 7,439,709 prescriptions | 51 | Penicillin, Cephalosporin, Macrolides, Quinolones, Sulfonamides, | Cefixime, Amoxicillin, Co-amoxiclav, Penicillin 6.3.3, Azithromycin, |
Karimi et al. [28] | Iran (all provinces) | 85 million prescriptions | 45 | NM | Amoxicillin |
Sadigh Rad et al. [86] | Urmia | 269,660 prescriptions | 39.29 | NM | NM |
Amani [87] | Ardabil | 2000 prescriptions | 52.8 | NM | Penicillin 6.3.3, Ceftriaxone, Penicillin 800,000 |
Hossein Zadeh et al. [88] | Ardabil | 2000 prescriptions | 54.9 | Penicillin, Cephalosporin, Macrolides | Cefixime, Azithromycin, Co-amoxiclav, Penicillin 6.3.3, Amoxicillin, |
Eftekhari Gol et al. [89] | Khorasan Razavi | 14,189 prescriptions | 50.8 | Nm | NM |
Ahmadi et al. [90] | Kermanshah | 352,399 prescriptions | 52.1 | NM | NM |
Rezazadeh et al. [91] | Tehran | 1035 prescriptions | 49.71 | NM | NM |
Soleymani et al. [92] | Tehran | 455,549 prescriptions | 30.1 | NM | NM |
 |  | Median: 14,189 | Median: 45.25 | Most prescribed: Penicillin, Cephalosporin, Macrolides, and Aminoglycosides | Most prescribed: Amoxicillin, Penicillin, Co-amoxiclav, and Cefixime |
IQR1: 2000 | IQR1: 39.2 | ||||
IQR3: 939,595 | IQR3: 53.33 |